Ausgabe 6/2018
Inhalt (10 Artikel)
The relationship between excitement symptom severity and extrastriatal dopamine D2/3 receptor availability in patients with schizophrenia: a high-resolution PET study with [18F]fallypride
Yo-Han Joo, Jeong-Hee Kim, Young-Don Son, Hang-Keun Kim, Yeon-Jeong Shin, Sang-Yoon Lee, Jong-Hoon Kim
Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort
G. Fond, N. Resseguier, F. Schürhoff, O. Godin, M. Andrianarisoa, L. Brunel, E. Bulzacka, B. Aouizerate, F. Berna, D. Capdevielle, I. Chereau, T. D’Amato, C. Dubertret, J. Dubreucq, C. Faget, F. Gabayet, C. Lançon, P. M. Llorca, J. Mallet, D. Misdrahi, C. Passerieux, R. Rey, A. Schandrin, M. Urbach, P. Vidailhet, L. Boyer, M. Leboyer, M. Andrianarisoa, B. Aouizerate, F. Berna, O. Blanc, L. Brunel, E. Bulzacka, D. Capdevielle, I. Chereau-Boudet, G. Chesnoy-Servanin, J. M. Danion, T. D’Amato, A. Deloge, C. Delorme, H. Denizot, J. M. Dorey, C. Dubertret, J. Dubreucq, C. Faget, C. Fluttaz, G. Fond, S. Fonteneau, F. Gabayet, E. Giraud-Baro, M. C. Hardy-Bayle, D. Lacelle, C. Lançon, H. Laouamri, M. Leboyer, T. Le Gloahec, Y. Le Strat, P. M. Llorca, J. Mallet, E. Metairie, D. Misdrahi, I. Offerlin-Meyer, C. Passerieux, P. Peri, S. Pires, C. Portalier, R. Rey, C. Roman, M. Sebilleau, A. Schandrin, F. Schürhoff, A. Tessier, A. M. Tronche, M. Urbach, F. Vaillant, A. Vehier, P. Vidailhet, J. Vilain, E. Vilà, H. Yazbek, A. Zinetti-Bertschy
Effects of haloperidol and clozapine on synapse-related gene expression in specific brain regions of male rats
Martina von Wilmsdorff, Fabian Manthey, Marie-Luise Bouvier, Oliver Staehlin, Peter Falkai, Eva Meisenzahl-Lechner, Andrea Schmitt, Peter J. Gebicke-Haerter
Elemental fingerprinting of schizophrenia patient blood plasma before and after treatment with antipsychotics
Alessandra Sussulini, Helena Munhoz Erbolato, Gustavo de Souza Pessôa, Marco Aurélio Zezzi Arruda, Johann Steiner, Daniel Martins-de-Souza
COMT and GAD1 gene polymorphisms are associated with impaired antisaccade task performance in schizophrenic patients
Anna V. Kirenskaya, Zinaida I. Storozheva, Marina A. Gruden, Robert D. E. Sewell
Identification of putative second genetic hits in schizophrenia carriers of high-risk copy number variants and resequencing in additional samples
Julio Rodríguez-López, Beatriz Sobrino, Jorge Amigo, Noa Carrera, Julio Brenlla, Santiago Agra, Eduardo Paz, Ángel Carracedo, Mario Páramo, Manuel Arrojo, Javier Costas
Negative symptoms, anxiety, and depression as mechanisms of change of a 12-month trial of assertive community treatment as part of integrated care in patients with first- and multi-episode schizophrenia spectrum disorders (ACCESS I trial)
Stefanie J. Schmidt, Matthias Lange, Daniel Schöttle, Anne Karow, Benno G. Schimmelmann, Martin Lambert
Correspondence between negative symptoms and potential sources of secondary negative symptoms over time
Aida Farreny, Mark Savill, Stefan Priebe
Effectiveness and cost-effectiveness of an integrated care program for schizophrenia: an analysis of routine data
Linda Kerkemeyer, Jürgen Wasem, Anja Neumann, Werner Brannath, Benjamin Mester, Jürgen Timm, Thomas Wobrock, Claudia Bartels, Peter Falkai, Janine Biermann